Literatura científica selecionada sobre o tema "Claims database"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Claims database".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Claims database"
1
Sato, Daisuke, Takeru Shiroiwa e Takashi Fukuda. "PP079 The Construction Of Database Using Japanese National Claims Database". International Journal of Technology Assessment in Health Care 33, S1 (2017): 108. http://dx.doi.org/10.1017/s0266462317002501.
Texto completo da fonteResumo:
INTRODUCTION:In 2014, the Ministry of Health, Labor and Welfare (MHLW) in Japan began to assume a cost-effectiveness perspective. Some expensive pharmaceutical and medical devices have been regulated, which resulted in a drastic change of the healthcare system.The Japanese National Insurance Claims Database (NDB) is an administrative database based on claims data from Medical Insurance Claims since 2008. The government enacted the Act on Assurance of Medical Care for Elderly People during health care reform in 2008. In 2006, the MHLW commenced discussions on a framework for the optimization of the healthcare expenses, which aimed to evaluate the structure of the increase in healthcare expenditure.The NDB was developed as a tool for investigation and analysis by the MHLW in the context of the Healthcare reform. In addition, the NDB was used for the development of academic research in order to contribute to the implementation and evaluation of healthcare policy management.A major strength of the NDB is its exhaustiveness or completeness of insurance claims. The NDB collects data from all insured people nationwide and covers all medical institutions in Japan.METHODS:We applied to the Expert Meeting on Provision of Medical Insurance Claims to examine the research plan, items extracted, and data management. Inpatient and Outpatient information was extracted on medical procedures and payment. Diagnoses for both inpatients and outpatients are coded according to the International Classification of Diseases Tenth Edition (ICD-10). The coding of treatments and surgeries follow Japan's local procedure and surgical coding, which was specifically developed for insurance claims.RESULTS:We generated any personally traceable patient ID from the “hash ID” generated by patient name, sex, date of birth, and insurer number with the aim of protecting personal identifying information in the NDB. The disease of stroke was defined to analyze the database for cost-effectiveness analysis, and to connect disease information to. The prescription claims information described pharmaceutical names, prescription date, total dose, and number of days.CONCLUSIONS:Our study showed the new standard way of analysis for cost-effectiveness analysis using the Japanese National Insurance Claims Database.
2
Park, Jin-Su, e Chan Hee Lee. "Clinical Study Using Healthcare Claims Database". Journal of Rheumatic Diseases 28, n.º 3 (1 de julho de 2021): 119–25. http://dx.doi.org/10.4078/jrd.2021.28.3.119.
Texto completo da fonte
3
Ruslawati Nik Mustapa, Nik, Najihan Awang Ali, Nurul Husna Jamian, Hussin Abdul Hamid, Syadatul Syaeda Mat Saleh e Roziana Baharain. "Personal Injury Claims (PIC) Database Modeling in Malaysia". International Journal of Engineering & Technology 7, n.º 4.33 (9 de dezembro de 2018): 106. http://dx.doi.org/10.14419/ijet.v7i4.33.23510.
Texto completo da fonteResumo:
Road accident often leads to claims for personal injury by aggrieved parties. In Malaysia, courts have been using multiplier-multiplicand approach. This approach seems to be outdated and unfair to the claimant. Presently, the approach excludes the claimant's personal condition in the calculation of quantum of damages. Hence, this study uses the Ogden Table as introduced in the United Kingdom as benchmarking guidelines, by taking into account of all aspect of claimant's personal condition for the purpose of such calculation. This study aim is to build upon a proposed data modeling system known as Entity Relationship Diagram (ERD) and the created process modeling known as data flow diagram (DFD). In so doing, the claimants will insert his input data, run it through the first process, and store the information in the claim injury part database. They can also edit and store to claim injury part database on their own. This will generate a report with the information in claim injury part database and can be viewed by claimant, court and lawyer as target users. It is hoped that it will facilitate the calculation of injury claim which would serve justice and accuracy of personal injury in road accidents.
4
Landis, Sarah H., Beth L. Nordstrom, Leah B. Sansbury, Sumitra Shantakumar, Samantha A. St Laurent, Kathy H. Fraeman e Jeanenne J. Nelson. "Disruptions in Liver Function among Cancer Patients and Patients Treated with Tyrosine Kinase Inhibiting Drugs: Comparisons of Two Population-Based Databases". Journal of Cancer Epidemiology 2013 (2013): 1–11. http://dx.doi.org/10.1155/2013/358285.
Texto completo da fonteResumo:
Liver toxicity is a recognized adverse event associated with small molecule tyrosine kinase inhibitors (TKIs). Electronic Medical Record (EMR) databases offer the most precise data to investigate the rate of liver function test (LFT) elevations; however, they can be limited in sample size and costly to access and analyze. Health insurance claims databases often contain larger samples sizes but may lack key health information. We evaluated the feasibility of utilizing a large claims database to calculate incidence rates (IRs) of LFT elevations among a general cohort of cancer patients and a cohort of patients treated with TKIs by comparing the results to a “gold standard” oncology-specific EMR database. IRs for the TKI cohorts were very similar between the two databases; however, IRs were higher in the EMR database for the cancer cohorts. Possible explanations for these differences include lack of specificity when defining a cancer case, poor capture of laboratory data, or inaccurate assessment of person-time in the insurance claims database. This study suggests that insurance claims data may provide reliable results when investigating liver toxicities associated with oncology drug exposure; however, there are limitations when assessing laboratory outcomes for cohorts defined solely by disease status.
5
Tabner, Andrew, Nicholas Tilbury, Michael Jones, Apostolos Fakis, Nicola Evans e Graham Johnson. "Trends in emergency department litigation within the NHS: a retrospective database analysis". Medico-Legal Journal 90, n.º 1 (14 de fevereiro de 2022): 5–12. http://dx.doi.org/10.1177/00258172211057000.
Texto completo da fonteResumo:
The objectives of this study are to examine trends in litigation related to emergency department care within the NHS. The study is based on retrospective database analysis. NHS Resolution databases of litigation activity pertaining to Type I emergency departments within the NHS are used. The main outcome measures were number of claims, number of successful claims, costs associated with litigation and costs per claim, all in comparison to patterns of ED attendance numbers and inflation. The results showed that the annual cost of litigation relating to emergency department care within the NHS has increased from £25.5 million in 2005/6 to £161.9 million in 2017/18. Mean cost per claim has increased from £58,252 in 2005/6 to £168,966 in 2017/18. The number of claims received has increased significantly; the proportion of these which were successful has remained constant. Therefore, it was concluded that the costs of litigation are increasing disproportionately to inflation and attendance numbers. Multiple potential causes are discussed, with significant implications for clinical practice.
6
Schaefer, Eric, Evangelos Messaris, Christopher Hollenbeak e Audrey Kulaylat. "Truven Health Analytics MarketScan Databases for Clinical Research in Colon and Rectal Surgery". Clinics in Colon and Rectal Surgery 32, n.º 01 (janeiro de 2019): 054–60. http://dx.doi.org/10.1055/s-0038-1673354.
Texto completo da fonteResumo:
AbstractThe MarketScan databases are a family of administrative claims databases that contain data on inpatient and outpatient claims, outpatient prescription claims, clinical utilization records, and healthcare expenditures. The three main databases available for use are each composed of a convenience sample for one of the following patient populations: (1) patients with employer-based health insurance from contributing employers, (2) Medicare beneficiaries who possess supplemental insurance paid by their employers, and (3) patients with Medicaid in one of eleven participating states. Eleven supplemental databases are available, which are utilized to overcome the limited clinical data available in the core MarketScan databases. There are several limitations to this database, primarily related to the fact that individuals or their family members within two of the core databases mandatorily possess some form of employer-based health insurance, which prevents the dataset from being nationally representative. Nonetheless, this database provides detailed and rigorously maintained claims data to identify healthcare utilization patterns among this cohort of patients.
7
Yonekura, Hiroshi, Yusuke Mazda, Shohei Noguchi, Hironaka Tsunobuchi e Motomu Shimaoka. "Current Epidemiology of the General Anesthesia Practice for Cesarean Delivery Using a Nationwide Claims Database in Japan: A Descriptive Study". Journal of Clinical Medicine 11, n.º 16 (17 de agosto de 2022): 4808. http://dx.doi.org/10.3390/jcm11164808.
Texto completo da fonteResumo:
The current status of general anesthesia practice for cesarean delivery in Japan remains unknown. Therefore, using a nationwide claims database, we aimed to investigate general anesthesia use for cesarean delivery over a period of 15 years, and to analyze the general anesthesia practice in Japan. Patients who claimed the Japanese general anesthesia claim code (L008) for cesarean delivery between 1 January 2005, and 31 March 2020, were analyzed. Primary endpoint was the prevalence of general anesthesia use. We used two definitions of general anesthesia: L008 code only (insurance definition) and combination of the L008 code with muscle relaxant use (clinical definition). The general anesthesia claim cohort (L008) included 10,972 cesarean deliveries at 1111 institutions from 2005 to 2020. Muscle relaxants were used in 27.3% of L008 claims cases. The rate of general anesthesia use for cesarean delivery ranged from 3.9% in clinical definition to 14.4% in insurance definition of all cesarean deliveries. We observed a temporal trend of gradual decrease in general anesthesia use, regardless of its definition (p for trend < 0.001). We recommend the clinical definition of general anesthesia as the combination of L008 code and muscle relaxant use in a claims-based approach.
8
Marshall, E. "METABOLIC RESEARCH: Canadian Group Claims 'Unique' Database". Science 315, n.º 5812 (2 de fevereiro de 2007): 583b—584b. http://dx.doi.org/10.1126/science.315.5812.583b.
Texto completo da fonte
9
Ooba, Nobuhiro, Soko Setoguchi, Takashi Ando, Tsugumichi Sato, Takuhiro Yamaguchi, Mayumi Mochizuki e Kiyoshi Kubota. "Claims-Based Definition of Death in Japanese Claims Database: Validity and Implications". PLoS ONE 8, n.º 5 (31 de maio de 2013): e66116. http://dx.doi.org/10.1371/journal.pone.0066116.
Texto completo da fonte
10
Gupta, Ashwin, Ashley Snyder, Allen Kachalia, Scott Flanders, Sanjay Saint e Vineet Chopra. "Malpractice claims related to diagnostic errors in the hospital". BMJ Quality & Safety 27, n.º 1 (9 de agosto de 2017): 53–60. http://dx.doi.org/10.1136/bmjqs-2017-006774.
Texto completo da fonteResumo:
BackgroundLittle is known about the incidence or significance of diagnostic error in the inpatient setting. We used a malpractice claims database to examine incidence, predictors and consequences of diagnosis-related paid malpractice claims in hospitalised patients.MethodsThe US National Practitioner Database was used to identify paid malpractice claims occurring between 1 January 1999 and 31 December 2011. Patient and provider characteristics associated with paid claims were analysed using descriptive statistics. Differences between diagnosis-related paid claims and other paid claim types (eg, surgical, anaesthesia, medication) were assessed using Wilcoxon rank-sum and χ2 tests. Multivariable logistic regression was used to identify patient and provider factors associated with diagnosis-related paid claims. Trends for incidence of diagnosis-related paid claims and median annual payment were assessed using the Cochran-Armitage and non-parametric trend test.Results13 682 of 62 966 paid malpractice claims (22%) were diagnosis-related. Compared with other paid claim types, characteristics significantly associated with diagnosis-related paid claims were as follows: male patients, patient aged >50 years, provider aged <50 years and providers in the northeast region. Compared with other paid claim types, diagnosis-related paid claims were associated with 1.83 times more risk of disability (95% CI 1.75 to 1.91; p<0.001) and 2.33 times more risk of death (95% CI 2.23 to 2.43; p<0.001) than minor injury, after adjusting for patient and provider characteristics. Inpatient diagnostic error accounted for $5.7 billion in payments over the study period, and median diagnosis-related payments increased at a rate disproportionate to other types.ConclusionInpatient diagnosis-related malpractice payments are common and more often associated with disability and death than other claim types. Research focused on understanding and mitigating diagnostic errors in hospital settings is necessary.
Teses / dissertações sobre o assunto "Claims database"
1
Moore, Marna. "Usage analysis of dermatological products according to a medicine claims database / Marna Moore". Thesis, North-West University, 2006. http://hdl.handle.net/10394/1026.
Texto completo da fonteResumo:
A large number of people all over the world suffer from skin conditions. Dermatological
problems comprise about 10 % of a general practitioner's caseload and probably more for
pharmacists. The literature furthermore emphasises that skin diseases are becoming a significant
problem in the developing world. There is a need to establish an effective method to achieve
good health and quality of life for patients with dermatological problems.
The general objective of this study was to investigate the usage patterns and cost of
dermatological products in the private health care sector of South Africa by using a medicine
claims database. The focus was specifically on dermatological products with a prevalence of
more than 10 % in the database.
A quantitative retrospective drug utilisation research design was used to evaluate the usage
patterns and costs of dermatological products in three four-monthly intervals of 2001 and 2004.
Data were analysed by using the Statistical Analysis System, 9.1 (SAS). The dermatological
product groups for this study were antibacterial and antifungal drugs, corticosteroids and anti-acne
products and were analysed according to the MIMS classification.
Of all analysed prescriptions issued only 8.57 % (n = 126 447) during 2001 (N = 1 475 380) and
6.82 % (n = 177 122) during 2004 (N = 2 595 254) consisted of dermatological products. Of the
total number of products prescribed, the dermatological products constituted 4.77 %I
(n = 140 701) for 2001 (N = 2 95 1 326) and 3.77 % (n = 199 976) for 2004 (N = 5 305 882). The
total cost of the dermatological products was 4.98 % (n = R18 913 889.92) of the total cost of all
medicine products during 200 1 (N = R379 708 489). During 2004 (N = R66 1 223 146) the total
cost of dermatological products was 4.09 % (n = R27 025 540.48) of the total cost of all
medicine products in the database. The cost-prevalence index for 2001 and 2004 respectively
showed that the dermatological products were relatively expensive with values of 1.03 and 1.09.
The antibacterial and antifungal drugs, corticosteroids and anti-acne products represented 91.92
% (n = 129 336) and 87.97 % (n = 175 9 16) of all dermatological products during 2001 (N = 140
701) and 2004 (N = 199 976), respectively. These dermatological groups named above
represented 91.57 % (n = R17 319 645.61) and 85.85 '% (n = R23 200 594.71), respectively, of
the total cost of dermatological products during 200 1 (N = R18 9 13 889.92) and 2004 (N = R27
025 540.48).
It was further found that the majority of dermatological products prescribed during the research
periods was innovator products. The prevalence of innovator products for 2001 was 86.17 % (n
= 12 1 249) with a total cost representing 94.16 % (n = R17 809 603.12). For 2004 the prevalence
was 82.33 % (n = 164 640) with a total cost representing 91 .O1 '% (n = R24 594 923.72) of all the
dermatological products prescribed. The number of innovator and generic products claimed
during 2001 amounted to 86.17 % (n = 12 1 249) and 13.83 % (n = 19 452) respectively of the
total number of products claimed (N = 140 701). During 2004 the number of innovator and
generic products represented respectively 82.33 % (n = 164 640) and 17.67 O/o (n = 35 336) of the
total number of products claimed (N = 199 976).
The prevalence in the use of the dermatological products during 2004 increased with 55.25 %
from January to April versus September to December. The cost-prevalence index indicated that
the dermatological products were relatively expensive during January to August 2004. During
September to December 2004 the cost-prevalence decreased and indicated that dermatological
products became inexpensive.
The average cost of dermatological products during the 2004 study period showed that the cost
decreased. January to April (before implementation of the new single exit price structure) was
compared to September to December (after implementation of the new single exit price
structure). This comparison indicated that the average cost decreased by 22.88 %.
It can be summarised that the average cost in the last study period decreased due to the changed
price structure. The innovator products' prevalence was high and therefore more generics are
needed in dermatology. If more generics are used the total cost of dermatological products
might also decrease. The number of dermatological prescriptions increased towards 2004, but
this may be because of more members or more medical aids claiming through this database.Thesis (M.Pharm.)--North-West University, Potchefstroom Campus, 2006.
2
Mizuno, Kayoko. "Indications and outcomes of paediatric tracheotomy: a descriptive study using a Japanese claims database". Doctoral thesis, Kyoto University, 2021. http://hdl.handle.net/2433/263525.
Texto completo da fonte
3
McCulloch, Matthew, e Alysson Baumgart. "A Comparison of Two Methods of Medication Reconciliation". The University of Arizona, 2008. http://hdl.handle.net/10150/624320.
Texto completo da fonteResumo:
Class of 2008 AbstractObjectives: To compare the completeness of patient medication history collected upon admission at the University Medical Center (UMC) in Tucson, Arizona with that collected by RxAccordTM insurance claims database. Methods: An inferential retrospective chart review. A random list of 300 patients admitted to UMC from January 1, 2007 to June 30, 2007 who utilized specific insurance companies was obtained. Of those 300 patients, the first 100 patients found in the RxAccordTM database were included in this study. UMC recorded admission medication history was noted for each patient and compared against the RxAccordTM retail pharmacy adjudicated medication database. The main outcome measured was the number of medication discrepancies. The independent variable was the type of medication reconciliation conducted (RxAccordTM ) vs. physician compiled upon admission to UMC. Results: A total of ninety-five charts were used in this study. UMC admission medication reconciliation records had an average of 2.21 missing medications per patient whereas RxAccordTM had an average of 1.01 missing medications per patient. Of the medications missing on the RxAccordTM database, almost 50% (46/96) were OTC medications. On average, UMC had fifty-one medications that had discrepancies (i.e. route, strength or directions). On the other hand, RxAccordTM contained no discrepancies. A total of 17 out 95 records (18%) were missing medication reconciliation forms in their medical record. Conclusions: Information collected by RxAccordTM produced a more complete patient medication reconciliation history than that compiled upon admission at UMC. An insurance claims database may provide, a significantly more accurate method of medication reconciliation.
4
Mohammed, Sheila. "Evaluation of Occupational Risk Factors for Nurses and CNAs: Analysis of Florida Workers' Compensation Claims Database". Scholar Commons, 2013. http://scholarcommons.usf.edu/etd/4731.
Texto completo da fonteResumo:
Musculoskeletal injuries lead to most claims even though needlestick injuries receive the most attention. In 2010, health expenditures in the United States neared $2.6 trillion. CNAs, orderlies, and attendants had the highest rates of musculoskeletal disorders of all occupations with an incidence of 249 per 10,000 compared to 34 per 10,000 for all workers. The financial burden of back injuries in the healthcare industry is estimated to add up to $20 billion annually. Data was extracted for cause of injury, nature of injury and body part injured. Extracted data was analyzed both descriptively and by logistic and linear regression using SAS version 9.2. Results were significant for falls, lifting, being struck and pushing and pulling as major causes for injury. Regarding the nature of injury, sprains and strains constituted the majority of claims. The lower back was the body part most commonly injured in a claim. It was concluded that emphasis must be placed on risk factors for musculoskeletal injuries such as falls, lifting, temporal and environmental factors, age and lifestyle factors rather than needlestick injuries.
Results from this study will be used to characterize risk factors for occupational injuries in CNAs and nurses, and to devise and implement preventive measures, including new legislation, to curb such injuries.
5
Takeda, Chikashi. "Prophylactic sivelestat for esophagectomy and in-hospital mortality: a propensity score-matched analysis of claims database". Kyoto University, 2020. http://hdl.handle.net/2433/253147.
Texto completo da fonte
6
Takeshima, Nozomi. "Continuation and discontinuation of benzodiazepine prescriptions: A cohort study based on a large claims database in Japan". Kyoto University, 2016. http://hdl.handle.net/2433/215956.
Texto completo da fonte
7
Lodi, Sara. "Statistical Issues in using A Large Claims Database to Study the anti-inflammatory effect of statins in Rheumatoid Arthiritis". Thesis, London School of Hygiene and Tropical Medicine (University of London), 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.499290.
Texto completo da fonte
8
Burger, Johanita Riétte. "A drug utilisation review of the concept of metabolic syndrome using a South African medicines claims database / Burger JR". Thesis, North-West University, 2012. http://hdl.handle.net/10394/8072.
Texto completo da fonteResumo:
The aim of the study was to determine the prevalence, medicine prescribing patterns and direct treatment cost associated with the metabolic syndrome and its components in the private health care sector of South Africa. A two–dimensional research method was employed, consisting of a literature review and an empirical investigation. The objective of the literature review was to provide background to the study by conceptualising the metabolic syndrome and the components forming part thereof. The empirical investigation consisted of a descriptive, quantitative, retrospective drug utilisation review study, utilising medicine claims data sourced from a South African Pharmaceutical Benefit Management (PBM) company for the period January 1, 2005 to December 31, 2008. Data for a total 246 122 patients from 2005, 252 080 from 2006, 208 632 from 2007 and 196 242 from 2008, receiving at least one medicine item from the pharmacological medicine classes of antihypertensives (including diuretics, MIMS® classifications 7.3 and 16.1), hipolipidaemics (MIMS® classification 7.7) and antidiabetics (MIMS® classification 19.1) were analysed. Metabolic syndrome was defined according to the American Heart Association/National Heart, Lung and Blood Institute criteria, as patients with claims for 1 medicine item(s) per year from each of these drug classes.
Seventy one per cent (n = 261 036) of patients from 2005 met one risk selection criterion for the metabolic syndrome, compared with 69.9% from 2006 (n = 269 452), 66.6% (n = 226 264) from 2007 and 64.9% (n = 214 109) from 2008 (male:female ratio 1:1.5 for 2005–2008; age peak >45,60 year). A total 60 683 (4.0%, n = 1 509 621) of patients from the 2005 dataset met at least two risk criteria for the metabolic syndrome. This number of patients increased to reach 63 835 (4.1%, n = 1 558 090) in 2006, thereafter decreasing to 57 992 (4.9%, n = 1 178 596) in 2007 and 57 220 (5.9%, n = 974 497) in 2008. A total 5.7% (n = 246 122) of patients in 2005 met inclusion criteria for the metabolic syndrome, increasing to 6.5% (n = 252 080) in 2006, 7.8% (n = 208 632) in 2007 and 8.3% (n = 196 242) in 2008 (male to female ratio for 2005 – 2008:1.2:1). In general, prevalence increased from ~0.1% of patients aged >0,15 years to ~0.3% in those >15,30 years, ~6% in patients >30,45 years, ~40% in patients aged >60,75 years and ~20% in patients >75 years. The average prevalent age appeared earlier in males than in females by 2 years.
The average pill burden per prescription for patients from the 2005–metabolic syndrome category was 2.6 ± 1.43, compared with 2.6 ± 1.47 in 2006, 2.7 ± 1.52 in 2007 and 2.7 ± 1.53 in 2008, with a maximum of 16 items claimed per patient in 2005, 14 in 2006 and 2007, respectively and 19 in 2008. Antidiabetics, hipolipidaemics and antihypertensives were claimed in a ratio of 1:1:2 across the 4–year study period. A prescribing index of 20 medicine items (active substances) based on prescribing volume was established for metabolic syndrome patients; the 5 most claimed medicine items on this index was metformin, simvastatin, atorvastatin, insulin and gliclazide.
A total of 17 716 different treatment regimens was identified for patients from the 2008–metabolic syndrome category, containing from one to 12 different active substances per regimen. Overall 90.7% (n = 17 716) of treatment regimens contained between 3 and 7 different active substances per prescription; a further 3.3% contained 8 active substances each. The combination of indapamide and perindopril with amlodipine, or simvastatin and/or metformin had the highest prevalence among those regimens containing 3 active substances.
The total direct medicine treatment cost from the metabolic syndrome category amounted to R71.7 million in 2005, increasing to R94.7 million in 2008. Medical aid schemes contributed 90.0% (n = R71 724 445.88) towards these costs in 2005, decreasing to 86.0% (n = R94 690 393.54) in 2008. The average scheme contribution was R131.14 ± 135.64 (median R103.12) per medicine item in 2005, compared with R126.63 ± 133.65 (median R101.24) in 2006, R128.39 ± 141.69 (median R101.35) in 2007 and R122.45 ± 143.97 (median R94.27) in 2008. Patients paid the excess 10% (2005) to 14% (2008) of costs out–of–pocket for co–payments on medicine items at an average cost of R14.55 ± 34.26 (median R0.00) per item for 2005, compared with R15.80 ± 38.04 (median R0.00) during 2006, R16.61 ± 38.01 (median R0.00) in 2007 and R19.95 ± 40.06 (median R2.28) in 2008. The average annual direct medicine treatment cost for a patient from the metabolic syndrome category summed to R4 809.20 ± 4 057.46 (median R3 850.67) in 2005, compared with R5 053.34 ± 4 033.85 (median R4 041.16) in 2006, R5 503.88 ± 4 348.67 (median R4 357.79) in 2007 and R5 300.03 ± 4 433.93 (median R4 100.06) in 2008.
A total 7 050 patients (39.5%, n = 17 866) or approximately every third patient from the metabolic syndrome category had at least one other Chronic Disease List (CDL) condition during 2008. An average chronic disease count of 1.4 ± 0.63 (median 1) (range: 1–5) per patient was calculated. Diseases that co–occurred most were hypothyroidism (22.7%, n = 7 050), coronary artery disease (13.6%, n = 7 050), cardiac failure (10.7%, n = 7 050), asthma (7.3%, n = 7 050) and glaucoma (4.5%, n = 7 050).
In conclusion, this study established base–line estimates on the prevalence, medicine prescribing patterns and associated direct medicine treatment cost of patients with metabolic syndrome and/or those at risk for the development thereof in the private health care sector of South Africa, as defined by surrogate measures of criteria from the American Heart Association and National Blood Institute. Recommendations for future extensions and diversifications to the study were made.Thesis (PhD (Pharmacy Practice))--North-West University, Potchefstroom Campus, 2012.
9
Seletswane, Dineo Precious. "Usage patterns and cost analysis of angiotensin-converting enzyme (ACE) inhibitors using a medical aid claims database / Dineo Precious Seletswane". Thesis, North-West University, 2004. http://hdl.handle.net/10394/357.
Texto completo da fonteResumo:
ACE inhibitors have been widely used in the treatment of certain diseases of the
cardiovascular system, the major use being hypertension, since all ACE inhibitors are
prescribed for its treatment. ACE inhibitors is also used in the treatment of congestive
heart failure.
The angiotensin-converting enzyme (ACE) converts angiotensin 1 into angiotensin I1
and also stimulates the production of aldosterone (a hormone produced in the adrenal
glands that influences salt and water retention by the kidneys, increasing blood
volume and blood pressure).
The cost benefit, cost-effectiveness and cost utility of ACE inhibitors have not been
established. The objective of the study was to review and analyse the cost of ACE
inhibitors by using a medical aid claims database.
Data for the study population consisted of all prescriptions containing one or more
ACE inhibitor combinations and were extracted from the central database of
Interpharm datasystems for a period of one year, from 1 January 2001 to 31
December 2001. A total of 1 475 532 prescriptions containing a total of 2 953 244
ACE inhibitor items represented the study population.
Through the analysis of the general medicine utilisation patterns that were obtained
from the medicine claims database, it became evident that ACE inhibitor utilisation
contributes considerably to the total prevalence and cost of all the medicine items
available on the database. It constituted a total prevalence of 4,62% (n =1 475 532) of
all the prescriptions and a total prevalence of 2,31% (n =2 953 244) for all the
medicine items in the prescriptions with a cost of 3,65% (n =R379 91 1 472,OO).
It was concluded that in the analysis of ACE inhibitors according to the
innovator/generic classification, the majority of ACE inhibitors prescribed during the
twelve-month period were for the innovator product, with a prevalence of 82,56% (n
=68 162) and a cost of 89,11% (n =R13 863 080, 90). The utilisation of the generic
ACE inhibitors, with a prevalence of 17,44% (n =68 162) and at a cost of 10,89% (n
=R13 863 080, 90), was under-utilised. If the total number of prescriptions containing
innovator ACE inhibitors could be generically substituted, (37,54%) R5 204 392,68 in
cost expenditure could be saved over a twelve-month period. However, the fact that
not all the innovator ACE inhibitors have generic equivalents available must be taken
into account. If only the prescriptions containing ACE inhibitor items that have
generic equivalents were to be substituted with their generic equivalents, R899
751.29(6.5%) would be saved. This was found by adding all the costs saved by
substituting innovator drugs with their generics.
Consequently, it can be concluded that the extensive use of the innovator ACE
inhibitors could mean an exceptional increase in the cost expenditure associated with
ACE inhibitor therapy.
In completion of the study, recommendations were formulated as an aim to optimise
the utilisation of ACE inhibitor generic equivalents.Thesis (M. Pharm.)--North-West University, Potchefstroom Campus, 2004.
10
Van, Zyl Tiaan. "A longitudinal analysis of the prescribing patterns of anti–epileptic medicine by using a medicine claims database / T. van Zyl". Thesis, North-West University, 2010. http://hdl.handle.net/10394/4918.
Texto completo da fonteResumo:
The prevalence of epilepsy in society is general knowledge; however the impact on
social activity as well as other daily factors are not always fully recognised. Epilepsy
frequently poses a problem with regard to work–related activities (Heaney, 1999:44).
Moran et al. (2004:425) indicated that the major impacts of epilepsy on life were work
and school difficulties, driving prohibition, psychological and social life of which
restriction of work or schooling has the greatest impact on epileptic’s life. In all cases
the type, severity, and frequency of the seizures as well as the age would be relevant.
Davis et al. (2008:451) established that 39% of all epileptics were not adherent to their
therapy and in patients over 65 this was even higher at 43 %. Non–adherence with antiepileptic
medicine appears to be related to increased health care utilisation and costs
and may also lead to an increased probable accidents or injuries
The general objective was to investigate anti–epileptic medicine prescribing patterns
and treatment cost in a section of the private health care sector by using a medicine
claims database.
A retrospective drug utilisation study was done on the data claims from a pharmacy
benefit management company for the study period 1 January 2005 to 31 December
2008.
Firstly epilepsy was investigated in order to understand the disease and to determine
the prevalence and treatment thereof. It was found that epilepsy is still one of the most
common neurological conditions and according to the findings, 2 out of every hundred
patients were using anti–epileptic medicine in this section of the private health care
sector. To make this condition socially more acceptable and understandable, public
education for special target groups concerning the disorder must be conducted as well
as employment training programmes for people with epilepsy themselves. The utilisation patterns of anti–epileptic drugs were reviewed, analysed and interpreted.
It was determined that anti–epileptic medicine items are relatively expensive with
regards to other medicine items on the total database. With regard to gender, more
females are using anti–epileptic medicine than males on the database. The largest age
group of patients using anti–epileptic medicine, is between > 40 years and <= 64 years of
age. It was also clear that prevalence increase as age increase.
With regard to the different prescribers, the number of items prescribed by a general
practitioner was almost double that of the other prescribers. It was further established
that newer anti–epileptic medicines are more expensive than older anti–epileptic
medicine according to the cost per tablet in this section of the private health care
sector.
Carbamazepine and valproate were the two active ingredients that were most
frequently prescribed as a single item on a prescription. After a cost–minimisation
analysis was done, R134 685.66 could have been saved when generic substitution was
implemented.
The refill–adherence rate decreased as age increased. Only 30.46% of the trade
names was refilled according to acceptable refill–adherence rates. The refill–adherence
rate according to active ingredient showed that medicine items containing,
phenobarbitone/vit B or gabapentin had the lowest unacceptable refill–adherence rate.
The limitations for this study was stipulated and recommendations for further research
regarding anti–epileptic medicine were also made.Thesis (M.Pharm (Pharmacy Practice))--North-West University, Potchefstroom Campus, 2011.
Livros sobre o assunto "Claims database"
1
Grazier, Kyle L. Group medical insurance large claims database collection and analysis. Schaumburg, Ill: Society of Actuaries, 1997.
Encontre o texto completo da fonte
2
E, Sherman Gary. Mining Claims Information System: A database retrieval program for active mining claims in Alaska. [Washington, D.C.?]: U.S. Dept. of Interior, Bureau of Mines, 1994.
Encontre o texto completo da fonte
3
Kreidler, Mike. CLUE (Comprehensive Loss Underwriting Exchange). [Olympia, Wash.]: Washington State Office of the Insurance Commissioner, 2003.
Encontre o texto completo da fonte
4
Mathisen, Ralph W. Studies in the history, literature and society of Late Antiquity. Amsterdam: A.M. Hakkert, 1991.
Encontre o texto completo da fonte
5
Fiore, Jacqueline, Craig Bond e Shanthi Nataraj. Database of Potential Sources of Information on Fisheries, Tourism, and Oil Spill Claims. RAND Corporation, 2017. http://dx.doi.org/10.7249/tl248.
Texto completo da fonte
6
Identifying Predictors of Adverse Drug Reactions and Associated Costs using a Claims Database. Storming Media, 2002.
Encontre o texto completo da fonte
7
Horowitz, Joshua. Cervical Radicular Pain. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780190217518.003.0018.
Texto completo da fonteResumo:
Cervical radicular pain is a common reason for patients in pain to seek care from a pain physician. Differing from low back pain and lumbar radiculopathy, cervical radicular pain is often not related to disc protrusion alone but, rather, a combination of disc and degenerative pathologies, such as uncovertebral hypertrophy and spondylosis. Likewise, the natural history is quite favorable if no treatments are applied, mandating greater safety for the treatments applied. Indeed, the most recent American Society of Anesthesiologists closed claims database report suggests that adverse occurrences from procedural therapies for cervical radicular pain are increasing. This chapter broadly discusses the anatomy, pathophysiology, and various approaches to treatment of these disorders.
8
Ślusarski, Marek. Metody i modele oceny jakości danych przestrzennych. Publishing House of the University of Agriculture in Krakow, 2017. http://dx.doi.org/10.15576/978-83-66602-30-4.
Texto completo da fonteResumo:
The quality of data collected in official spatial databases is crucial in making strategic decisions as well as in the implementation of planning and design works. Awareness of the level of the quality of these data is also important for individual users of official spatial data. The author presents methods and models of description and evaluation of the quality of spatial data collected in public registers. Data describing the space in the highest degree of detail, which are collected in three databases: land and buildings registry (EGiB), geodetic registry of the land infrastructure network (GESUT) and in database of topographic objects (BDOT500) were analyzed. The results of the research concerned selected aspects of activities in terms of the spatial data quality. These activities include: the assessment of the accuracy of data collected in official spatial databases; determination of the uncertainty of the area of registry parcels, analysis of the risk of damage to the underground infrastructure network due to the quality of spatial data, construction of the quality model of data collected in official databases and visualization of the phenomenon of uncertainty in spatial data. The evaluation of the accuracy of data collected in official, large-scale spatial databases was based on a representative sample of data. The test sample was a set of deviations of coordinates with three variables dX, dY and Dl – deviations from the X and Y coordinates and the length of the point offset vector of the test sample in relation to its position recognized as a faultless. The compatibility of empirical data accuracy distributions with models (theoretical distributions of random variables) was investigated and also the accuracy of the spatial data has been assessed by means of the methods resistant to the outliers. In the process of determination of the accuracy of spatial data collected in public registers, the author’s solution was used – resistant method of the relative frequency. Weight functions, which modify (to varying degree) the sizes of the vectors Dl – the lengths of the points offset vector of the test sample in relation to their position recognized as a faultless were proposed. From the scope of the uncertainty of estimation of the area of registry parcels the impact of the errors of the geodetic network points was determined (points of reference and of the higher class networks) and the effect of the correlation between the coordinates of the same point on the accuracy of the determined plot area. The scope of the correction was determined (in EGiB database) of the plots area, calculated on the basis of re-measurements, performed using equivalent techniques (in terms of accuracy). The analysis of the risk of damage to the underground infrastructure network due to the low quality of spatial data is another research topic presented in the paper. Three main factors have been identified that influence the value of this risk: incompleteness of spatial data sets and insufficient accuracy of determination of the horizontal and vertical position of underground infrastructure. A method for estimation of the project risk has been developed (quantitative and qualitative) and the author’s risk estimation technique, based on the idea of fuzzy logic was proposed. Maps (2D and 3D) of the risk of damage to the underground infrastructure network were developed in the form of large-scale thematic maps, presenting the design risk in qualitative and quantitative form. The data quality model is a set of rules used to describe the quality of these data sets. The model that has been proposed defines a standardized approach for assessing and reporting the quality of EGiB, GESUT and BDOT500 spatial data bases. Quantitative and qualitative rules (automatic, office and field) of data sets control were defined. The minimum sample size and the number of eligible nonconformities in random samples were determined. The data quality elements were described using the following descriptors: range, measure, result, and type and unit of value. Data quality studies were performed according to the users needs. The values of impact weights were determined by the hierarchical analytical process method (AHP). The harmonization of conceptual models of EGiB, GESUT and BDOT500 databases with BDOT10k database was analysed too. It was found that the downloading and supplying of the information in BDOT10k creation and update processes from the analyzed registers are limited. An effective approach to providing spatial data sets users with information concerning data uncertainty are cartographic visualization techniques. Based on the author’s own experience and research works on the quality of official spatial database data examination, the set of methods for visualization of the uncertainty of data bases EGiB, GESUT and BDOT500 was defined. This set includes visualization techniques designed to present three types of uncertainty: location, attribute values and time. Uncertainty of the position was defined (for surface, line, and point objects) using several (three to five) visual variables. Uncertainty of attribute values and time uncertainty, describing (for example) completeness or timeliness of sets, are presented by means of three graphical variables. The research problems presented in the paper are of cognitive and application importance. They indicate on the possibility of effective evaluation of the quality of spatial data collected in public registers and may be an important element of the expert system.
9
Geological Survey (U.S.), ed. Procedure for making a mining claim density map from BLM claim recordation digital data. [Menlo Park, CA]: U.S. Dept. of the Interior, U.S. Geological Survey, 1996.
Encontre o texto completo da fonte
10
Friedman, Jeffrey A. War and Chance. Oxford University Press, 2019. http://dx.doi.org/10.1093/oso/9780190938024.001.0001.
Texto completo da fonteResumo:
War and Chance analyzes the logic, psychology, and politics of assessing uncertainty in international affairs. It explains how the most important kinds of uncertainty in international politics are inherently subjective, and yet how scholars, practitioners, and pundits can still debate these issues in clear and structured ways. Altogether, the book shows how foreign policy analysts can assess uncertainty in a manner that is theoretically coherent, empirically meaningful, politically defensible, practically useful, and sometimes logically necessary for making sound choices. Each of these claims contradicts widespread skepticism about the value of probabilistic reasoning in international politics, and shows how placing greater emphasis on assessing uncertainty can improve nearly any kind of foreign policy analysis or decision. The book substantiates this argument by examining critical episodes in the history of U.S. national security policy, such as strategic planning in Vietnam, assessments of Iraq’s weapons of mass destruction programs, and the search for Osama bin Laden. The book also draws on a diverse range of quantitative evidence, including a database containing nearly one million geopolitical forecasts and experimental studies involving hundreds of national security professionals.
Capítulos de livros sobre o assunto "Claims database"
1
Sato, Daisuke, e Kazuhiko Ohe. "Japan—National Insurance Claims Database (NDB)". In Databases for Pharmacoepidemiological Research, 267–74. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-51455-6_22.
Texto completo da fonte
2
Sanfilippo, Emilio M., e Richard Freedman. "Ontology for Analytic Claims in Music". In New Trends in Database and Information Systems, 559–71. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-031-15743-1_51.
Texto completo da fonte
3
Moore, Nicholas, Patrick Blin, Régis Lassalle, Nicolas Thurin, Pauline Bosco-Levy e Cécile Droz. "National Health Insurance Claims Database in France (SNIRAM), Système Nationale des Données de Santé (SNDS) and Health Data Hub (HDH)". In Databases for Pharmacoepidemiological Research, 131–40. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-51455-6_10.
Texto completo da fonte
4
Hennessy, Sean, Cristin Palumbo Freeman e Francesca Cunningham. "US Government Claims Databases". In Pharmacoepidemiology, 209–23. Oxford, UK: Wiley-Blackwell, 2012. http://dx.doi.org/10.1002/9781119959946.ch14.
Texto completo da fonte
5
Collen, Morris F. "Bio-Surveillance and Claims Databases". In Health Informatics, 195–215. London: Springer London, 2011. http://dx.doi.org/10.1007/978-0-85729-962-8_7.
Texto completo da fonte
6
Mikoš, Matjaž. "Landslide Research and Technology in Patent Documents". In Progress in Landslide Research and Technology, Volume 1 Issue 2, 2022, 29–48. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-18471-0_3.
Texto completo da fonteResumo:
AbstractScience, Technology, and Innovation play a crucial role in the Sendai Framework for Disaster Risk Reduction 2015–2030 (SF DRR). The International Consortium on Landslides (ICL) initiated the Sendai Landslide Partnerships 2015–2025 as a voluntary commitment to SF DRR. In 2020, the ICL launched the Kyoto 2020 Commitment for Global Promotion of Understanding and Reducing Landslide Disaster Risk (KLC 2020) as a follow-up of the Sendai Landslide Partnerships 2015–2025. Closely related to the above-mentioned Innovation are patents as a form of intellectual property rights and are often used as an innovation assessment parameter. This article reports on a study conducted to look at the patent documents that are available in open-access databases in order to evaluate how well they relate to the field of landslide research and technology. Landslide-related patent documents were extracted using different search terms in the patent document titles, abstracts, claims and/or their general text from the Google Patents, using the Espacenet tools from the European Patent Office, and the Derwent Patent Index inside the Web of Science offered by Clarivate Analytics, respectively. The extracted patent documents were analyzed with regard to the applicant respectively inventor affiliation (academic, non-academic, country of affiliation) and to the technical field of a patent using well-known patent classifications. The most active countries claiming landslide-related patents were recognized. Furthermore, review and research articles in SpringerLink and SCOPUS databases were searched to study how often scientific articles are citing landslide-related patents. The results of the study can be summarized as follow: (i) in the Google Patents database there are 15,000 + landslide-related patent documents, and in the Espacenet and the Derwent Innovation index database 5000+, respectively. In the patents titles, abstracts, and claims, processes are more often used to describe the patent than the technology; (ii) the number of technological (non-science) based patents is higher than that of academic (science-based) patents, with some specific field of applications, where the situation is the opposite; (iii) with regard to the different areas of technology to which landslide-related patent documents pertain, the categories “G-Physics” and “E-Fixed constructions” are clearly prevailing: “G” for debris flows and landslides, and “E” for fallings rocks and mudflows; (iv) the majority of landslide-related patents are filled and/or granted in China, followed by Japan and South Korea, USA and EU member countries—five major emerging economies (called BRICS) are outperforming developed countries, with a very prevailing Chinese contribution; (v) only a fraction of the order of a few one-in-thousands of landslide-related patents documents are cited in journal review and research articles.
7
Karayiannis, Christos. "The MySQL Database Server". In Web-Based Projects that Rock the Class, 219–68. Berkeley, CA: Apress, 2019. http://dx.doi.org/10.1007/978-1-4842-4463-0_6.
Texto completo da fonte
8
Lee, Sang-Hyun, Sang-Joon Lee e Kyung-Il Moon. "Application of Fuzzy Feedback Control for Warranty Claim". In New Challenges for Intelligent Information and Database Systems, 279–88. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-19953-0_28.
Texto completo da fonte
9
Haynes, Kevin. "Electronic Health Record, Transactional Insurance Claims, and Distributed Databases in Pharmacovigilance". In Methods in Pharmacology and Toxicology, 135–48. New York, NY: Springer New York, 2018. http://dx.doi.org/10.1007/978-1-4939-8818-1_7.
Texto completo da fonte
10
Galindo, F., e E. Albertos. "The prototype work payment claim (ARPO), as the first step towards the construction of an aid program for legal decisions". In Database and Expert Systems Applications, 290–95. Vienna: Springer Vienna, 1990. http://dx.doi.org/10.1007/978-3-7091-7553-8_47.
Texto completo da fonteTrabalhos de conferências sobre o assunto "Claims database"
1
Ferguson, G. T., R. Brown, A. Patel, C. Tafur, Z. Babcock e S. Colilla. "Assessing Real-World Uncontrolled COPD Therapy Using a US Administrative Claims Database". In American Thoracic Society 2021 International Conference, May 14-19, 2021 - San Diego, CA. American Thoracic Society, 2021. http://dx.doi.org/10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2259.
Texto completo da fonte
2
Subar, M., SA Lust e W. Lin. "Abstract S4-7: Compliance with Mammographic Screening Guidelines from an Administrative Claims Database". In Abstracts: Thirty-Third Annual CTRC‐AACR San Antonio Breast Cancer Symposium‐‐ Dec 8‐12, 2010; San Antonio, TX. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/0008-5472.sabcs10-s4-7.
Texto completo da fonte
3
Lee, SangHyun, CheolMin Kim, SoonJa Yeom, Gwiyeon Kim, KyungIl Moon e ByungGi Kim. "A Study on Development of Time Series Warning Module in Warranty Claims Database". In Sixth International Conference on Advanced Language Processing and Web Information Technology (ALPIT 2007). IEEE, 2007. http://dx.doi.org/10.1109/alpit.2007.71.
Texto completo da fonte
4
Suruki, Robert Y., Kourtney J. Davis e Hector G. Ortega. "Exacerbation Frequency Among Pediatric Patients With Asthma In A Us Healthcare Claims Database". In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a3751.
Texto completo da fonte
5
Tanaka, Y., T. Matsuki, A. Mizukami, A. Kobayashi e C. Ito. "409 Disease severity and burden in japanese patients with systemic lupus erythematosus from claims database". In LUPUS 2017 & ACA 2017, (12th International Congress on SLE &, 7th Asian Congress on Autoimmunity). Lupus Foundation of America, 2017. http://dx.doi.org/10.1136/lupus-2017-000215.409.
Texto completo da fonte
6
Suruki, Robert Y., Kourtney J. Davis e Hector G. Ortega. "Frequency Of Asthma Exacerbation By Severity In Adult Patients Using A US Healthcare Claims Database". In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a5227.
Texto completo da fonte
7
Goto, Shoichiro, e Gabriela Ispas. "LATE-BREAKING ABSTRACT: Evaluation on RSV disease burden in Japanese children using a nationwide claims database". In ERS International Congress 2016 abstracts. European Respiratory Society, 2016. http://dx.doi.org/10.1183/13993003.congress-2016.pa1324.
Texto completo da fonte
8
Cook, Michael B., Daniel C. Beachler, Lauren E. Parlett, Philip T. Cochetti, William D. Finkle, Stephan Lanes e Robert N. Hoover. "Abstract 5050: Testosterone supplementation in relation to prostate cancer in a US commercial insurance claims database". In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-5050.
Texto completo da fonte
9
Cook, Michael B., Daniel C. Beachler, Lauren E. Parlett, Philip T. Cochetti, William D. Finkle, Stephan Lanes e Robert N. Hoover. "Abstract 5050: Testosterone supplementation in relation to prostate cancer in a US commercial insurance claims database". In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-5050.
Texto completo da fonte
10
Butler, O., S. Ju, S. Teal, S. Hoernig, K. Vogtlaender, S. Bansilal e G. A. Heresi. "Monitoring for Persistent Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Following Pulmonary Endarterectomy (PEA): A US Claims Database Analysis". In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6582.
Texto completo da fonteRelatórios de organizações sobre o assunto "Claims database"
1
O'Neill, Francis, Kristofer Lasko e Elena Sava. Snow-covered region improvements to a support vector machine-based semi-automated land cover mapping decision support tool. Engineer Research and Development Center (U.S.), novembro de 2022. http://dx.doi.org/10.21079/11681/45842.
Texto completo da fonteResumo:
This work builds on the original semi-automated land cover mapping algorithm and quantifies improvements to class accuracy, analyzes the results, and conducts a more in-depth accuracy assessment in conjunction with test sites and the National Land Cover Database (NLCD). This algorithm uses support vector machines trained on data collected across the continental United States to generate a pre-trained model for inclusion into a decision support tool within ArcGIS Pro. Version 2 includes an additional snow cover class and accounts for snow cover effects within the other land cover classes. Overall accuracy across the continental United States for Version 2 is 75% on snow-covered pixels and 69% on snow-free pixels, versus 16% and 66% for Version 1. However, combining the “crop” and “low vegetation” classes improves these values to 86% for snow and 83% for snow-free, compared to 19% and 83% for Version 1. This merging is justified by their spectral similarity, the difference between crop and low vegetation falling closer to land use than land cover. The Version 2 tool is built into a Python-based ArcGIS toolbox, allowing users to leverage the pre-trained model—along with image splitting and parallel processing techniques—for their land cover type map generation needs.
2
Neyedley, K., J. J. Hanley, Z. Zajacz e M. Fayek. Accessory mineral thermobarometry, trace element chemistry, and stable O isotope systematics, Mooshla Intrusive Complex (MIC), Doyon-Bousquet-LaRonde mining camp, Abitibi greenstone belt, Québec. Natural Resources Canada/CMSS/Information Management, 2021. http://dx.doi.org/10.4095/328986.
Texto completo da fonteResumo:
The Mooshla Intrusive Complex (MIC) is an Archean polyphase magmatic body located in the Doyon-Bousquet-LaRonde (DBL) mining camp of the Abitibi greenstone belt, Québec, that is spatially associated with numerous gold (Au)-rich VMS, epizonal 'intrusion-related' Au-Cu vein systems, and shear zone-hosted (orogenic?) Au deposits. To elucidate the P-T conditions of crystallization, and oxidation state of the MIC magmas, accessory minerals (zircon, rutile, titanite) have been characterized using a variety of analytical techniques (e.g., trace element thermobarometry). The resulting trace element and oxythermobarometric database for accessory minerals in the MIC represents the first examination of such parameters in an Archean magmatic complex in a world-class mineralized district. Mineral thermobarometry yields P-T constraints on accessory mineral crystallization consistent with the expected conditions of tonalite-trondhjemite-granite (TTG) magma genesis, well above peak metamorphic conditions in the DBL camp. Together with textural observations, and mineral trace element data, the P-T estimates reassert that the studied minerals are of magmatic origin and not a product of metamorphism. Oxygen fugacity constraints indicate that while the magmas are relatively oxidizing (as indicated by the presence of magmatic epidote, titanite, and anhydrite), zircon trace element systematics indicate that the magmas were not as oxidized as arc magmas in younger (post-Archean) porphyry environments. The data presented provides first constraints on the depth and other conditions of melt generation and crystallization of the MIC. The P-T estimates and qualitative fO2 constraints have significant implications for the overall model for formation (crystallization, emplacement) of the MIC and potentially related mineral deposits.
3
Ruiz, Pablo, Craig Perry, Alejando Garcia, Magali Guichardot, Michael Foguer, Joseph Ingram, Michelle Prats, Carlos Pulido, Robert Shamblin e Kevin Whelan. The Everglades National Park and Big Cypress National Preserve vegetation mapping project: Interim report—Northwest Coastal Everglades (Region 4), Everglades National Park (revised with costs). National Park Service, novembro de 2020. http://dx.doi.org/10.36967/nrr-2279586.
Texto completo da fonteResumo:
The Everglades National Park and Big Cypress National Preserve vegetation mapping project is part of the Comprehensive Everglades Restoration Plan (CERP). It is a cooperative effort between the South Florida Water Management District (SFWMD), the United States Army Corps of Engineers (USACE), and the National Park Service’s (NPS) Vegetation Mapping Inventory Program (VMI). The goal of this project is to produce a spatially and thematically accurate vegetation map of Everglades National Park and Big Cypress National Preserve prior to the completion of restoration efforts associated with CERP. This spatial product will serve as a record of baseline vegetation conditions for the purpose of: (1) documenting changes to the spatial extent, pattern, and proportion of plant communities within these two federally-managed units as they respond to hydrologic modifications resulting from the implementation of the CERP; and (2) providing vegetation and land-cover information to NPS park managers and scientists for use in park management, resource management, research, and monitoring. This mapping project covers an area of approximately 7,400 square kilometers (1.84 million acres [ac]) and consists of seven mapping regions: four regions in Everglades National Park, Regions 1–4, and three in Big Cypress National Preserve, Regions 5–7. The report focuses on the mapping effort associated with the Northwest Coastal Everglades (NWCE), Region 4 , in Everglades National Park. The NWCE encompasses a total area of 1,278 square kilometers (493.7 square miles [sq mi], or 315,955 ac) and is geographically located to the south of Big Cypress National Preserve, west of Shark River Slough (Region 1), and north of the Southwest Coastal Everglades (Region 3). Photo-interpretation was performed by superimposing a 50 × 50-meter (164 × 164-feet [ft] or 0.25 hectare [0.61 ac]) grid cell vector matrix over stereoscopic, 30 centimeters (11.8 inches) spatial resolution, color-infrared aerial imagery on a digital photogrammetric workstation. Photo-interpreters identified the dominant community in each cell by applying majority-rule algorithms, recognizing community-specific spectral signatures, and referencing an extensive ground-truth database. The dominant vegetation community within each grid cell was classified using a hierarchical classification system developed specifically for this project. Additionally, photo-interpreters categorized the absolute cover of cattail (Typha sp.) and any invasive species detected as either: Sparse (10–49%), Dominant (50–89%), or Monotypic (90–100%). A total of 178 thematic classes were used to map the NWCE. The most common vegetation classes are Mixed Mangrove Forest-Mixed and Transitional Bayhead Shrubland. These two communities accounted for about 10%, each, of the mapping area. Other notable classes include Short Sawgrass Marsh-Dense (8.1% of the map area), Mixed Graminoid Freshwater Marsh (4.7% of the map area), and Black Mangrove Forest (4.5% of the map area). The NWCE vegetation map has a thematic class accuracy of 88.4% with a lower 90th Percentile Confidence Interval of 84.5%.
4
Shamblin, Robert, Kevin Whelan, Mario Londono e Judd Patterson. South Florida/Caribbean Network early detection protocol for exotic plants: Corridors of invasiveness. National Park Service, julho de 2022. http://dx.doi.org/10.36967/nrr-2293364.
Texto completo da fonteResumo:
Exotic plant populations can be potentially catastrophic to the natural communities of South Florida. Aggressive exotics such as Brazillian Pepper (Schinus terebinthifolius) and Melaleuca (Melaleuca quinquinervia) have displaced native habitats and formed monocultures of exotic stands (Dalrymple et al. 2003). Nearby plant nurseries, especially the ones outside the boundaries of Biscayne National Park (BISC) and Everglades National Park (EVER), are a continuous source of new exotic species that may become established within South Florida’s national parks. Early detection and rapid response to these new species of exotic plants is important to maintaining the integrity of the parks’ natural habitats and is a cost-effective approach to management. The South Florida/Caribbean Network (SFCN) developed the South Florida/Caribbean Network Early Detection Protocol for Exotic Plants to target early detection of these potential invaders. Three national parks of South Florida are monitored for invasive, exotic plants using this protocol: Big Cypress National Preserve (BICY), Biscayne National Park (BISC), and Everglades National Park (EVER). These national parks include some 2,411,000 acres (3,767.2 square miles [mi2]) that encompass a variety of habitat types. To monitor the entire area for new species would not be feasible; therefore the basic approach of this protocol is to scan major “corridors of invasiveness,” e.g., paved and unpaved roads, trails, trail heads, off road vehicle (ORV) trails, boat ramps, canals, and campgrounds, for exotic plant species new to the national parks of South Florida. Sampling is optimized using a two- to three-person crew: a trained botanist, a certified herbicide applicator, and optionally a SFCN (or IPMT [Invasive Plant Management Team]) staff member or park staff to take photographs and help with data collection. If infestations are small, they are treated immediately by the herbicide applicator. If large, they are reported to park staff and the Invasive Plant Management Team. The sampling domain is partitioned into five regions, with one region sampled per year. Regions include the terrestrial habitats of Biscayne National Park, the eastern region of Everglades National Park, the western region of Everglades National Park, the northern region of Big Cypress National Preserve, and the southern region of Big Cypress National Preserve. Monitoring of roads, trails, and canals occurs while traveling into and through the parks (i.e., travel at 2–10 mph) using motorized vehicles, airboats, and/or hiking. Campgrounds, boat launches, trailheads, and similar areas, involve complete searches. When an exotic plant is observed, a GPS location is obtained, and coordinates are taken of the plant. Photographs are not taken for every exotic plant encountered, but photographs will be taken for new and unusual species (for example a coastal exotic found in inland habitats). Information recorded at each location includes the species name, size of infestation, abundance, cover class, any treatment/control action taken, and relevant notes. During the surveys, a GPS “track” is also recorded to document the areas surveyed and a field of view is estimated. Field notes, pictures, and GPS data are compiled, entered, and analyzed in a Microsoft Access database. Resource briefs (and optional data summary reports) and associated shapefiles and data are then produced and sent to contacts within the corresponding national parks.
5
Totten, Annette, Dana M. Womack, Marian S. McDonagh, Cynthia Davis-O’Reilly, Jessica C. Griffin, Ian Blazina, Sara Grusing e Nancy Elder. Improving Rural Health Through Telehealth-Guided Provider-to-Provider Communication. Agency for Healthcare Research and Quality, dezembro de 2022. http://dx.doi.org/10.23970/ahrqepccer254.
Texto completo da fonteResumo:
Objectives. To assess the use, effectiveness, and implementation of telehealth-supported provider-to-provider communication and collaboration for the provision of healthcare services to rural populations and to inform a scientific workshop convened by the National Institutes of Health Office of Disease Prevention on October 12–14, 2021. Data sources. We conducted a comprehensive literature search of Ovid MEDLINE®, CINAHL®, Embase®, and Cochrane CENTRAL. We searched for articles published from January 1, 2015, to October 12, 2021, to identify data on use of rural provider-to-provider telehealth (Key Question 1) and the same databases for articles published January 1, 2010, to October 12, 2021, for studies of effectiveness and implementation (Key Questions 2 and 3) and to identify methodological weaknesses in the research (Key Question 4). Additional sources were identified through reference lists, stakeholder suggestions, and responses to a Federal Register notice. Review methods. Our methods followed the Agency for Healthcare Research and Quality Methods Guide (available at https://effectivehealthcare.ahrq.gov/topics/cer-methods-guide/overview) and the PRISMA reporting guidelines. We used predefined criteria and dual review of abstracts and full-text articles to identify research results on (1) regional or national use, (2) effectiveness, (3) barriers and facilitators to implementation, and (4) methodological weakness in studies of provider-to-provider telehealth for rural populations. We assessed the risk of bias of the effectiveness studies using criteria specific to the different study designs and evaluated strength of evidence (SOE) for studies of similar telehealth interventions with similar outcomes. We categorized barriers and facilitators to implementation using the Consolidated Framework for Implementation Research (CFIR) and summarized methodological weaknesses of studies. Results. We included 166 studies reported in 179 publications. Studies on the degree of uptake of provider-to-provider telehealth were limited to specific clinical uses (pharmacy, psychiatry, emergency care, and stroke management) in seven studies using national or regional surveys and claims data. They reported variability across States and regions, but increasing uptake over time. Ninety-seven studies (20 trials and 77 observational studies) evaluated the effectiveness of provider-to-provider telehealth in rural settings, finding that there may be similar rates of transfers and lengths of stay with telehealth for inpatient consultations; similar mortality rates for remote intensive care unit care; similar clinical outcomes and transfer rates for neonates; improvements in medication adherence and treatment response in outpatient care for depression; improvements in some clinical monitoring measures for diabetes with endocrinology or pharmacy outpatient consultations; similar mortality or time to treatment when used to support emergency assessment and management of stroke, heart attack, or chest pain at rural hospitals; and similar rates of appropriate versus inappropriate transfers of critical care and trauma patients with specialist telehealth consultations for rural emergency departments (SOE: low). Studies of telehealth for education and mentoring of rural healthcare providers may result in intended changes in provider behavior and increases in provider knowledge, confidence, and self-efficacy (SOE: low). Patient outcomes were not frequently reported for telehealth provider education, but two studies reported improvement (SOE: low). Evidence for telehealth interventions for other clinical uses and outcomes was insufficient. We identified 67 program evaluations and qualitative studies that identified barriers and facilitators to rural provider-to-provider telehealth. Success was linked to well-functioning technology; sufficient resources, including time, staff, leadership, and equipment; and adequate payment or reimbursement. Some considerations may be unique to implementation of provider-to-provider telehealth in rural areas. These include the need for consultants to better understand the rural context; regional initiatives that pool resources among rural organizations that may not be able to support telehealth individually; and programs that can support care for infrequent as well as frequent clinical situations in rural practices. An assessment of methodological weaknesses found that studies were limited by less rigorous study designs, small sample sizes, and lack of analyses that address risks for bias. A key weakness was that studies did not assess or attempt to adjust for the risk that temporal changes may impact the results in studies that compared outcomes before and after telehealth implementation. Conclusions. While the evidence base is limited, what is available suggests that telehealth supporting provider-to-provider communications and collaboration may be beneficial. Telehealth studies report better patient outcomes in some clinical scenarios (e.g., outpatient care for depression or diabetes, education/mentoring) where telehealth interventions increase access to expertise and high-quality care. In other applications (e.g., inpatient care, emergency care), telehealth results in patient outcomes that are similar to usual care, which may be interpreted as a benefit when the purpose of telehealth is to make equivalent services available locally to rural residents. Most barriers to implementation are common to practice change efforts. Methodological weaknesses stem from weaker study designs, such as before-after studies, and small numbers of participants. The rapid increase in the use of telehealth in response to the Coronavirus disease 2019 (COVID-19) pandemic is likely to produce more data and offer opportunities for more rigorous studies.
6
Greater-than-Class C low-level radioactive waste characterization. Appendix A-1: Nuclear utility data outputs from the GNUPS database. Office of Scientific and Technical Information (OSTI), setembro de 1994. http://dx.doi.org/10.2172/132667.
Texto completo da fonte
7
MGR Quarterly Infographics Report: August-October 2022. Microgovernance Research Initiative, 2022. http://dx.doi.org/10.57074/mgr1022022.
Texto completo da fonteResumo:
The Microgovernance Research Initiative (MGR) has been publishing infographics on conflict and violence in order to understand the latest trends and dynamics of conflict in Bangladesh. This infographic report is produced from the violence monitoring database that identifies and codes events of unrest, conflict, and violence in Bangladesh. Coding is based on a detailed codebook, a list of different variables, and codes about specific places, types, actors, victims, lethal and non-lethal causalities, etc. While MGR strives to record incidents as precisely and accurately as possible, the initiative makes no claim and guarantee about the accuracy or biases of ‘news contents’, as we collect all the data from different newspapers with different backgrounds publicly available. However, it follows several methods, caveats, and safeguards to maintain accuracy and adequacy throughout the process. The infographics include data from around 127 local and national newspapers- online and offline.
8
Monthly Infographics Report: December 2022. Microgovernance Research Initiative (MGR), 2023. http://dx.doi.org/10.57189/mgrinfdec22.
Texto completo da fonteResumo:
The Microgovernance Research Initiative (MGR) has been publishing monthly infographics on a regular basis to understand the latest trends and dynamics of conflict and violence in Bangladesh. This infographic report is produced from the violence monitoring database that identifies and codes events of unrest, conflict, and violence in Bangladesh. Coding is based on a detailed codebook, a list of different variables, and codes about specific places, types, actors, victims, lethal and non-lethal causalities, etc. While MGR strives to record incidents as precisely and accurately as possible, the initiative makes no claim and guarantee about the accuracy or biases of ‘news contents’, as we collect all the data from different newspapers with different backgrounds publicly available. However, it follows several methods, caveats, and safeguards to maintain accuracy and adequacy throughout the process. The infographics include data from around 127 local and national newspapers- online and offline.
9
Monthly Infographics Report: November 2022. Microgovernance Research Initiative (MGR), novembro de 2022. http://dx.doi.org/10.57189/mgrinfnov22.
Texto completo da fonteResumo:
The Microgovernance Research Initiative (MGR) has been pub- lishing monthly and quarterly infographics on a regular basis to understand the latest trends and dynamics of conflict and vio- lence in Bangladesh. This infographic report is produced from the violence monitoring database that identifies and codes events of unrest, conflict, and violence in Bangladesh. Coding is based on a detailed codebook, a list of different variables, and codes about specific places, types, actors, victims, lethal and non-lethal cau- salities, etc. While MGR strives to record incidents as precisely and accurately as possible, the initiative makes no claim and guar- antee about the accuracy or biases of ‘news contents’, as we col- lect all the data from different newspapers with different back- grounds publicly available. However, it follows several methods, caveats, and safeguards to maintain accuracy and adequacy throughout the process. The infographics include data from around 127 local and national newspapers- online and offline.